REQUEST A DEMO
Total
USD $0.00
Search more companies

Andrologia Fernando Vasquez Rengifo S.A.S. (Colombia)

Main Activities: Other Ambulatory Health Care Services
Full name: Andrologia Fernando Vasquez Rengifo S.A.S. Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Andrologia Fernando Vasquez Rengifo S.A.S. is an enterprise based in Colombia. Its main office is in PuertoColombia. It operates in the Other Ambulatory Health Care Services industry. The company was established on October 01, 2015. From the latest financial highlights, Andrologia Fernando Vasquez Rengifo S.A.S. reported a net sales revenue drop of 19.32% in 2023. Its’ total assets recorded a growth of 17.61%. In, 2023, the company’s net profit margin increased by 0.77%.

Headquarters
Cr 30 No 01 B - 850 Co 619
PuertoColombia; Atlantico;

Contact Details: Purchase the Andrologia Fernando Vasquez Rengifo S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Andrologia Fernando Vasquez Rengifo S.A.S. report to view the information.
Incorporation Date:
October 01, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Andrologia Fernando Vasquez Rengifo S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-19.32%
Total operating revenue
-19.32%
Operating profit (EBIT)
-10.77%
Net Profit (Loss) for the Period
-10.77%
Total assets
17.61%
Total equity
12.87%
Operating Profit Margin (ROS)
0.77%
Net Profit Margin
0.77%
Return on Equity (ROE)
-3.02%
Quick Ratio
-78.12%
Cash Ratio
-16.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?